Shukra Pharmaceuticals Ltd Peer Comparison
524632 · Healthcare · Current price
Peers tracked
16
Shukra Pharmaceuticals Ltd P/E
236.1x
Sector
Healthcare
Shukra Pharmaceuticals Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Divis Laboratories Ltd | ₹9,322 | 69.1x | 2,47,479 |
| Zydus Lifesciences Ltd | ₹1,119.1 | 22.0x | 1,12,612 |
| Cipla Ltd | ₹1,366 | 30.3x | 1,10,332 |
| Laurus Labs Ltd | ₹1,969 | 92.8x | 1,06,200 |
| Aurobindo Pharma Ltd | ₹1,679.8 | 25.9x | 97,564 |
| Dr Reddys Laboratories Ltd | ₹1,165.5 | 26.8x | 97,276 |
| Lupin Ltd | ₹2,095 | 20.6x | 95,784 |
| Mankind Pharma Ltd | ₹2,280 | 53.7x | 94,138 |
| Glenmark Pharmaceuticals Ltd | ₹2,419.2 | 45.5x | 68,295 |
| Biocon Ltd | ₹390.65 | 175.9x | 62,895 |
| Alkem Laboratories Ltd | ₹5,087.5 | 28.6x | 60,830 |
| Abbott India Ltd | ₹25,550 | 35.2x | 54,291 |
Shukra Pharmaceuticals Ltd versus its peers
Shukra Pharmaceuticals Ltd operates in the Healthcare space alongside 16 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 236.1x may be cheap in one industry and expensive in another.
More on Shukra Pharmaceuticals Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.